Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Acute Myeloid Leukemia · Myelodysplastic Syndrome · Myelodysplastic Syndrome/Acute Myeloid Leukemia · Recurrent Acute Myeloid Leukemia · Recurrent Myelodysplastic Syndrome · Recurrent Myelodysplastic Syndrome/Acute Myeloid Leukemia · Refractory Acute Myeloid Leukemia · Refractory Myelodysplastic Syndrome · Refractory Myelodysplastic Syndrome/Acute Myeloid Leukemia

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Yale University, New Haven, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Maximilian Stahl)
  • Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 404-778-1868
    Contact: Principal Investigator (Michael J. Hochman)
  • University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Olatoyosi M. Odenike)
  • UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, United States

  • University of Chicago Medicine-Orland Park, Orland Park, Illinois, United States

  • UChicago Medicine Northwest Indiana, Crown Point, Indiana, United States

  • University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · 800-888-8823
    Contact: Principal Investigator (Vu H. Duong)
  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 877-442-3324
    Contact: Principal Investigator (Evan C. Chen)
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Meagan Jacoby)
  • Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Meagan Jacoby)
  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Meagan Jacoby)
  • Siteman Cancer Center-South County, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Meagan Jacoby)
  • Siteman Cancer Center at Christian Hospital, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Meagan Jacoby)
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Tamanna Haque)
  • Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Tamanna Haque)
  • Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Tamanna Haque)
  • Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 732-235-7356
    Contact: Principal Investigator (Neil D. Palmisiano)
  • Memorial Sloan Kettering Commack, Commack, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Tamanna Haque)
  • Memorial Sloan Kettering Westchester, Harrison, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Tamanna Haque)
  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Tamanna Haque)
  • Memorial Sloan Kettering Nassau, Uniondale, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Tamanna Haque)
  • Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 336-713-6771
    Contact: Principal Investigator (Madelyn Burkart)
מובילי המחקר
  • Evan C Chen

    Principal Investigator

    Dana-Farber - Harvard Cancer Center LAO